University Of Pittsburgh

The FDA approved etranacogene dezaparvovec-drlb, a single-dose gene therapy for treatment of adults with hemophilia B.

In this video, John M. Skaugen, MD, an assistant professor of pathology at University of Pittsburgh discusses his study presented at the American Thyroid Association 2022 annual meeting.

PHILADELPHIA — Rheumatologists are unlikely to be held liable under a state’s anti-abortion laws for prescribing methotrexate for a rheumatic disease, according to a law professor who spoke at ACR Convergence 2022.

In patients with fibrotic interstitial lung disease, exposure to small particulate matter was linked to increased mortality, poor lung function and faster disease progression, according to a study in JAMA Internal Medicine.

NASHVILLE, Tenn. — In this Healio exclusive, Belinda Natalia Rivera-Lebron, MD, MS, highlights the role of artificial intelligence as a tool for acute pulmonary embolism risk stratification.

NASHVILLE, Tenn. — Idiopathic pulmonary fibrosis appeared associated with increased mortality rates and worse outcomes among in-hospital cardiac arrest survivors, according to study results presented at the CHEST Annual Meeting.

Prescription rates of SGLT2 inhibitors and GLP-1 receptor agonists among adults with type 2 diabetes in the Veterans Health Administration varied by race, with white patients most likely to receive these medications.

The University of Pittsburgh School of Medicine announced MaCalus V. Hogan, MD, MBA, as its new David Silver Professor and chair of the department of orthopedic surgery, according to a press release.

Researchers at the University of Pittsburgh Medical Center found a 5% incidence of unexpected positive sonication cultures with at least five colony-forming units in patients undergoing presumed aseptic revision total joint arthroplasty.

It is quite possible that, when all is said and done, the most lasting impact of COVID-19 on rheumatology will be the overwhelming uptake of telemedicine in daily clinical practice.